Lawrence J Jasinski Lemaitre Vascular Inc (LMAT) insider trading activity

Lawrence J Jasinski is Director of LEMAITRE VASCULAR INC. Currently has a direct ownership of 5,544 shares of LMAT, which is worth approximately $510,713. The most recent transaction as insider was on Dec 12, 2024, when has been sold 6 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.54K

4.43% 3M change

43.57% 12M change

Total Value Held $510,713

Lawrence J Jasinski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2024	BUY Exercise of conversion of derivative security	-	6 Added 0.11%	5,544 Common Stock
Dec 11 2024	BUY Exercise of conversion of derivative security	-	6 Added 0.11%	5,538 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	1 Added 0.02%	5,532 Common Stock
Dec 06 2024	BUY Grant, award, or other acquisition	-	420 Added 7.06%	5,531 Common Stock
Nov 20 2024	SELL Open market or private sale	$20,493 $103.5 p/Share	198 Reduced 3.73%	5,111 Common Stock
Mar 05 2024	SELL Open market or private sale	$344,925 $67.5 p/Share	5,110 Reduced 49.05%	5,309 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	1 Added 0.01%	10,419 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	593 Added 5.39%	10,418 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	-	1 Added 0.01%	9,825 Common Stock
Dec 11 2023	BUY Exercise of conversion of derivative security	-	2 Added 0.02%	9,824 Common Stock
Dec 08 2023	BUY Grant, award, or other acquisition	-	512 Added 4.95%	9,822 Common Stock
May 09 2023	SELL Open market or private sale	$240,768 $66.0 p/Share	3,648 Reduced 28.15%	9,310 Common Stock
May 09 2023	BUY Exercise of conversion of derivative security	$153,361 $42.04 p/Share	3,648 Added 21.97%	12,958 Common Stock
Mar 02 2023	SELL Open market or private sale	$9,600 $50.0 p/Share	192 Reduced 2.02%	9,310 Common Stock
Dec 12 2022	BUY Grant, award, or other acquisition	-	593 Added 5.87%	9,502 Common Stock
Dec 02 2022	SELL Open market or private sale	$470,700 $47.07 p/Share	10,000 Reduced 52.88%	8,909 Common Stock
Dec 02 2022	BUY Exercise of conversion of derivative security	$321,100 $32.11 p/Share	10,000 Added 34.59%	18,909 Common Stock
Dec 11 2021	BUY Grant, award, or other acquisition	$27,994 $48.6 p/Share	576 Added 6.07%	8,909 Common Stock
Mar 01 2021	SELL Open market or private sale	$384,600 $51.28 p/Share	7,500 Reduced 47.37%	8,333 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$225,825 $30.11 p/Share	7,500 Added 32.14%	15,833 Common Stock
Nov 24 2020	SELL Open market or private sale	$296,250 $39.5 p/Share	7,500 Reduced 47.37%	8,333 Common Stock
Nov 24 2020	BUY Exercise of conversion of derivative security	$205,725 $27.43 p/Share	7,500 Added 32.14%	15,833 Common Stock

Also insider at

RWLK

ReWalk Robotics Ltd. Healthcare

Chief Executive Officer

LJJ